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ThroughputFour custom Axiom genotyping arrays were designed for a genome-wide association (GWA) study of 100,000
participants from the Kaiser Permanente Research Program on Genes, Environment and Health. The array op-
timized for individuals of European race/ethnicity was previously described. Here we detail the development
of three additional microarrays optimized for individuals of East Asian, African American, and Latino race/
ethnicity. For these arrays, we decreased redundancy of high-performing SNPs to increase SNP capacity.
The East Asian array was designed using greedy pairwise SNP selection. However, removing SNPs from the
target set based on imputation coverage is more efﬁcient than pairwise tagging. Therefore, we developed a
novel hybrid SNP selection method for the African American and Latino arrays utilizing rounds of greedy pair-
wise SNP selection, followed by removal from the target set of SNPs covered by imputation. The arrays pro-
vide excellent genome-wide coverage and are valuable additions for large-scale GWA studies.minor allele frequency; KGP, 1000 Genomes Project; RPGEH
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Genome-wide association (GWA) studies have produced a large
number of replicated novel genetic variants [1–4] for many diseasesfor which no variants had been previously found. The success of these
studies has been a result of high-throughput genotyping platforms
assaying hundreds of thousands to a million SNPs, with large sample
sizes leading to an increased number of replicated associations [5,6]., Research Program on Genes, Environment and Health; EUR, Euro-
frican Ancestry in Southwest USA; CEU, Utah residents with ancestry
HS, Han Chinese South; CLM, Colombian in Medellin, Colombia; Fin,
o; LWK, Luhya inWebuye Kenya; MXL, Mexican in Los Angeles, CA;
ss; KPNC, Kaiser Permanente Northern California; AIMs, Ancestry In-
Ave, Suite S965, Box 0794, San Francisco, CA94143-0794, USA. Fax:+1
80.
A. Fax: +1 510 891 3761.
e, Suite S965, Box 0794, San Francisco, CA 94143-0794, USA. Fax: +1
y.schaefer@kp.org (C. Schaefer), pui.kwok@ucsf.edu (P.-Y. Kwok),
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0.1<=MAF<0.2 (8072 SNPs)
0.05<=MAF<0.1 (4661 SNPs)
0.04<=MAF<0.05 (1126 SNPs)
0.03<=MAF<0.04 (1203 SNPs)
0.02<=MAF<0.03 (1173 SNPs)
Fig. 1. Chromosome 21 coverage of the African Ancestry in Southwest USA (ASW) pop-
ulation based on two hypothetical arrays, one designed by pairwise tagging and the
other by hybrid SNP selection for the Yoruba in Ibadan (YRI) population. Coverage
was based on imputation using the YRI population as reference. The numbers in paren-
theses in the legend are the numbers of markers in the target set in each particular
minor allele frequency range.
423T.J. Hoffmann et al. / Genomics 98 (2011) 422–430Many of these have focused on common genetic variation (MAF (minor
allele frequency) of 0.10 or greater), based on the HapMap catalog [7].
Sequencing projects, particularly the 1000 Genomes Project (KGP)
(http://www.1000genomes.org), are developing larger catalogs which
can be leveraged to design arrays that assay lower frequency variants,
further enabling discovery of disease-associated genetic variations.
Here we describe the development of three new microarrays for
the Axiom Genotyping Solution tailored to individuals of East Asian,
African American, and Latino race/ethnicity. These are the remaining
three of four custom microarrays developed for the genome-wide
genotyping analysis of 100,000 participants in the Kaiser Permanente
Research Program on Genes, Environment and Health (RPGEH). A de-
scription of the genotyping project and RPGEH cohort is included in
[8]. Axiom arrays are limited to approximately 700,000 SNPs when
SNPs are tiled with two replicates, which is the standard. Budget con-
straints for this project allowed for the genotyping of either a single
array on 100,000 individuals or two arrays (up to 1.4 million SNPs)
on 50,000 individuals. We opted to genotype 100,000 individuals
with a single array. As a consequence, however, we chose to design
four different arrays to maximize genome-wide coverage, especially
for lower frequency variants, in each of the major US race/ethnicity
groups (African Americans, East Asians, Latinos and Whites) repre-
sented in the RPGEH cohort.
The design of the ﬁrst array in the series, optimized for US whites
(designated EUR), has been described [8]. The East Asian (EAS) array
was designed for individuals of East Asian ancestry, although we also
included SNPs to provide coverage of European-speciﬁc variants to
accommodate some RPGEH subjects with mixed East Asian/European
ancestry. The target set for the African American (AFR) array included
both West African and European variants, recognizing the mixed
ancestry of African Americans. Because Latinos have ancestry from
three continents, we targeted SNPs common and speciﬁc to
Europeans, West Africans and Native Americans for the Latino (LAT)
array. These arrays were developed to maximize the number of high
resolution SNPs for genome-wide coverage; to saturate regions previ-
ously identiﬁed as disease associated from prior GWA studies for both
replication and ﬁne mapping; to improve coverage of both common
and uncommon variants by making use of data from the low pass
and high pass phases of the KGP; and to incorporate redundant cover-
age of SNPs with known strong disease associations [8]. For the EAS,
AFR and LAT arrays, we used several approaches to enhance the over-
all genome-wide coverage, including modiﬁcation to the SNP selec-
tion algorithm and reduction of the number of replicates for some
SNPs on the array to create more space for additional SNPs.
There have been several methods proposed for SNP selection,
starting with a greedy pairwise correlation (“tagging”) algorithm
[9]. There have also been efforts to extend pairwise tagging to tagging
using multi-marker correlations to increase efﬁciency [10]. However,
to our knowledge, less has been done with imputation for tagging,
aside from using it to tag singleton SNPs [8].
Imputation has played a major role in the analysis of genome-
wide association data [11]; here we explore its use in the design of
genotyping microarrays. Imputation of missing SNPs using HapMap
reference samples can lead to an overall increase in power of up to
10% [12], and is becoming possible with larger sequenced reference
panels, e.g., from the KGP. Simulations show that imputation is poten-
tially the most beneﬁcial for rare variants, which are harder to tag
with a single marker [13]. Several papers that imputed all variants
in HapMap found signiﬁcant associations with imputed SNPs that
would not have been found by analyzing only the SNPs on the GWA
array [14]. Motivated by this analysis strategy of imputing all variants
from a reference panel, in this paper, we describe a novel hybrid de-
sign method for selection of SNPs for genotype microarrays. The
method uses alternating rounds of SNP selection based on pairwise
tagging followed by rounds of target set coverage calculations based
on imputation r2 values, which enables removal from the target setof SNPs that can be covered by imputation but were not covered by
pairwise tagging. Using this approach, we were able to increase
genome-wide coverage with the same ﬁxed number of SNPs on the
designed array.
The three new custom arrays described here utilize the AxiomGenoty-
ping Solution (http://media.affymetrix.com/support/technical/datasheets/
axiom_genotyping_solution_datasheet.pdf). Brieﬂy, it is a two-color
ligation-based assay utilizing 30-mer oligonucleotide probes synthe-
sized in situ on a microarray substrate with automated parallel proces-
sing of 96 samples per plate, with a total of ~1.38 million features
available for experimental content. In the design of the EUR array,
every SNP was represented by at least 2 features (2-rep); some high-
value SNPs that had poor resolution were tiled on the array with more
than two representations, and hence required more than 2 features
(e.g., 4 features or 8 features). As a consequence, the EUR array contains
a total of 674,518 SNPs. At the time of design of the EAS, AFR and LAT
arrays, it became apparent through analysis of the two representations
on the EUR array that the highest resolution SNPs could be tiled on the
array with a single feature with only a very small reduction in call rate.
We therefore increased the genome-wide coverage of these arrays by
tiling some of the highest resolution SNPs with only a single feature
(1-rep), enabling greater SNP content on the arrays.
At the time of design of the AFR and LAT arrays, Affymetrix intro-
duced a new reagent kit, Axiom Reagent Kit 2.0. An increased number
of SNPs were validated by Affymetrix on the new kit, providing a larger
sample of candidate SNPs for the design of these two arrays. The beneﬁts
were two-fold: more of the primary, secondary and tertiary SNPs could
be directly tiled onto the arrays, and a wider choice of high resolution
SNPs were available for selection for genome-wide coverage.2. Results
2.1. Genome-wide coverage algorithm comparison
Results in Fig. 1 for the HapMap sample African Ancestry in
Southwest USA (ASW) and Fig. 2 for the Luhya in Webuye, Kenya
(LWK) compare coverage for a hypothetical array designed in the
r2
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Fig. 2. Chromosome 21 coverage of the Luhya in Webuye, Kenya (LWK) population
based on two hypothetical arrays, one designed by pairwise tagging and the other by
hybrid SNP selection for the Yoruba in Ibadan (YRI) population. Coverage was based
on imputation using the YRI population as reference. The numbers in parentheses are
the numbers of markers in the target set in each particular minor allele frequency
range.
424 T.J. Hoffmann et al. / Genomics 98 (2011) 422–430Yoruba in Ibadan population (YRI) by hybrid SNP selection to one
designed by pairwise tagging (on chromosome 21), and show that
the hybrid SNP selection algorithm outperforms the pairwise tagging
selection algorithm by an average of about 5% on all coverage curves.
During the course of hybrid SNP selection in creating this hypotheti-
cal array, we noted that the number of SNPs marked as covered by
the imputation piece of the algorithm was 28,788 (87%), compared
with 19,293 (58%) marked as covered by simple pairwise tagging. A
separate analysis of chromosome 20 produced similar results. As a
consequence, we proceeded to design both the AFR and LAT arrays
using the hybrid SNP selection strategy described in Section 4.1. The
EAS array, which required fewer SNPs for genome wide coverage,
was designed by traditional pairwise tagging SNP selection.
2.2. Array statistics
The four arrays developed for the genotyping project on the Kaiser
Permanente RPGEH were optimized for individuals of varying ances-
tries. The design of the EUR array is given elsewhere [8]; the design of
the remaining 3 arrays is given below in Section 4.3.2. The collection
of SNPs on the four arrays differed, although there was considerable
overlap. It was part of the design algorithm to maximize the overlap
of SNP content between the arrays. Table 1 provides a description of
SNP content for the four arrays, including a breakdown by type (auto-
somal, X-linked, Y-linked or mitochondrial), the number of 1-rep
SNPs on each of the arrays (the SNPs tiled with one representation
were only those selected for genome-wide coverage), and theTable 1
The number of SNPs that are common to each of the arrays, broken down by type, and the nu
the count for the X chromosome.
Overlap with other arrays
Array EUR EAS AFR LAT
EUR 674,518 386,841 384,966 434,028
EAS 712,950 303,850 314,794
AFR 893,631 574,940
LAT 817,810number of overlapping SNPs between the different arrays. Among
the four arrays, 804,385 SNPs were unique to a single array;
403,981 were shared by two arrays; 156,270 were shared by three ar-
rays; and 254,438 were shared by all four arrays. In total, 1,619,074
unique SNPs were included on at least one array.
The design of each array, as described for the EUR array [8], in-
volved selection of SNPs from a preselect set that was prioritized for
inclusion and a target set for which SNPs were selected for coverage.
The preselect set consisted of three tiers of the most important SNPs
described below in Section 4.3.1 (e.g., related to disease) that were di-
rectly tiled on the array before other rounds of SNP selection began
[8]. The EAS array had 258 SNPs in the primary tier; 9764 in the sec-
ondary; and 43,908 in the tertiary. The AFR array had 270 primary;
16,669 secondary; and 43,398 tertiary. Lastly, the LAT array had 279
primary; 20,020 secondary; and 43,398 tertiary. The increasing num-
ber of secondary SNPs on the AFR and LAT arrays is primarily a result
of the availability of more validated SNPs at the time the array was
designed, due to the greater numbers of SNPs available for use with
the new Affymetrix Axiom Reagent Kit 2.0 and to the increasing
SNP requirement due to decreased LD in African ancestry populations
for imputing missing SNPs.
2.3. Genome-wide coverage of the arrays
Coverage was computed for each array against an appropriate tar-
get population by calculating imputation r2 values. To obtain an unbi-
ased estimate of coverage, we used chromosome 2 sequence data of
the 1000 Genomes Project interim June 2011 release data (KG2011)
(http://1000genomes.org) consisting of 1094 individuals of 14
race/ethnicities: 61 ASW, 87 Utah residents with ancestry from
Northern and Western Europe from Centre d'Etude du Polymor-
phisme Humain (CEU), 97 Han Chinese in Beijing (CHB), 100 Han
Chinese South (CHS), 60 Colombian in Medellin, Colombia (CLM), 93
Finnish individuals from Finland (FIN), 89 British individuals
from England and Scotland (GBR), 14 Iberians in Spain (IBS), 89
Japanese (JPT), 97 LWK, 66 HapMap Mexican individuals from Los
Angeles, California (MXL), 55 Puerto Ricans in Puerto Rico (PUR), 98
Toscani in Italia (TSI), and 88 YRI. To compute coverage, all subjects
other than the target group were included in the reference set. For
example, for the 97 target Chinese in Beijing (CHB) individuals, we
used all other populations except CHB in the reference sample.
Imputation accuracy is affected by the size of the reference sample,
among other things [15]. Our reference and target panels vary slightly
amongst the different populations; however, the sizes are sufﬁciently
large and similar that results are comparable.
The EAS array was designed to cover SNPs from the ASI popula-
tion (up to 90 CHB and 89 JPT unrelated HapMap 3 individuals [16]
using HapMap and Axiom validated dbSNP and KGP SNPs) with
MAF≥0.02, and SNPs from the CEU population (up to 116 unrelated
HapMap 3 CEU individuals [16], using HapMap and Axiom validated
dbSNP and KGP SNPs) with MAF≥0.10. To obtain an unbiased esti-
mate of genome-wide coverage, we used the KG2011 data for the im-
putation calculation, as described above. Results are given in Fig. 3 for
CHB. This dataset was sequenced at a low (average ~5×) coverage
[17,18], and some genotype calls for these subjects were improvedmber with a single feature (1-rep). SNPs in the pseudoautosomal region are included in
Type breakdown Features
Mitochondrial Y X Autosomal 1-rep
116 289 13,123 660,990 0
83 158 13,385 699,324 65,473
98 234 26,264 867,035 429,451
123 234 25,397 792,056 282,901
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0.05<=MAF<0.1 (99489 SNPs)
0.04<=MAF<0.05 (28130 SNPs)
0.03<=MAF<0.04 (34096 SNPs)
0.02<=MAF<0.03 (48302 SNPs)
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KGLP∩KGHP
0.1<=MAF (232519 SNPs)
0.05<=MAF<0.1 (36478 SNPs)
0.04<=MAF<0.05 (8520 SNPs)
0.03<=MAF<0.04 (8974 SNPs)
0.02<=MAF<0.03 (10206 SNPs)
0.01<=MAF<0.02 (13266 SNPs)
Fig. 3. Chromosome 2 coverage by the new AX_KP_UCSF_EAS array of the 1000 Ge-
nomes interim June 2011 (KG2011) Han Chinese in Beijing (CHB) genotypes. Coverage
was based on imputation of the target CHB set using all other individuals except CHB.
The numbers in parentheses in the legend are the numbers of markers in the target set
in each particular minor allele frequency range. Subsets refer to SNPs identiﬁed in the
1000 Genomes High Pass (KGHP) sequencing (indicated by solid lines with “KGLP ∩
KGHP”) versus all SNPs (indicated by dashed lines with “KGLP, All SNPs”).
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Fig. 5. Chromosome 2 coverage by the new AX_KP_UCSF_LAT array of the 1000 Genomes
interim June 2011 release (KG2011) Mexicans in Los Angeles, CA (MXL) genotypes. Cov-
erage was based on imputation of the target MXL set using all other individuals except
MXL. The numbers in parentheses in the legend are the numbers of markers in the target
set in each particular minor allele frequency range. Subsets refer to SNPs identiﬁed in the
1000 Genomes High Pass (KGHP) sequencing (indicated by solid lines with “KGLP ∩
KGHP”) versus all SNPs (indicated by dashed lines with “KGLP, All SNPs”).
425T.J. Hoffmann et al. / Genomics 98 (2011) 422–430through imputation from HapMap 3 data [19]. Hence, because of po-
tential noise in the low pass sequencing phase of the KGP, in Fig. 3 we
also display coverage of the subset of SNPs also found in the 1000 Ge-
nomes High Pass (KGHP) data (coverage of 20–60×). Because these
high quality SNPs were derived from sequencing only two trios,
they are biased towards more common allele frequencies. However,
this set still contains low frequency variants, and we have stratiﬁed
the results based on MAF ranges found in the ASI. As can be seen in
the ﬁgure, coverage is excellent down to a MAF of 0.01. We note0.0 0.2 0.4 0.6 0.8 1.0
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Fig. 4. Chromosome 2 coverage by the new AX_KP_UCSF_AFR array of the 1000 Ge-
nomes interim June 2011 release (KG2011) African Ancestry in Southwest USA
(ASW) genotypes. Coverage was based on imputation of the target ASW set using all
other individuals except ASW. The numbers in parentheses in the legend are the num-
bers of markers in the target set in each particular minor allele frequency range. Sub-
sets refer to SNPs identiﬁed in the 1000 Genomes High Pass (KGHP) sequencing
(indicated by solid lines with “KGLP ∩ KGHP”) versus all SNPs (indicated by dashed
lines with “KGLP, All SNPs”).that coverage of the subset of KGHP SNPs is considerably better
than for the KG2011 SNPs as a whole. As we have reported before
[8], this is likely due, at least in part, to the low coverage sequence
data containing inaccurate genotype calls and false positive SNPs
due to the low pass sequencing. Results were nearly identical for im-
putation coverage in CHS using all other individuals except CHS, as
well as in JPT using all individuals but JPT (results not shown).
The AFR array was designed to cover SNPs from the YRI population
(up to 116 unrelated HapMap 3 individuals [16] using HapMap
and Axiom validated dbSNP and KGP SNPs) with MAF≥0.02, and0.0 0.2 0.4 0.6 0.8 1.0
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Fig. 6. Chromosome 2 coverage by the new AX_KP_UCSF_LAT array of the 1000 Genomes
interim June 2011 release (KG2011) Puerto Rican in Puerto Rico (PUR) genotypes. Cover-
age was based on imputation of the target PUR set using all other individuals except PUR.
The numbers in parentheses in the legend are the numbers of markers in the target set in
each particular minor allele frequency range. Subsets refer to SNPs identiﬁed in the 1000
Genomes High Pass (KGHP) sequencing (indicated by solid lines with “KGLP ∩ KGHP”)
versus all SNPs (indicated by dashed lines with “KGLP, All SNPs”).
426 T.J. Hoffmann et al. / Genomics 98 (2011) 422–430SNPs from the CEU population (same genotypes as in EAS array) with
MAF≥0.10. Coverage results for the 61 KG2011 ASW individuals are
given in Fig. 4. Coverage is excellent for MAF of 0.04 or greater at an
r2 of 0.8, and still good for MAF of 0.01 or greater. This reﬂects the in-
creased genetic variation and decreased linkage disequilibrium ob-
served in the YRI population.
The LAT array was designed to cover YRI SNPs with a MAF≥0.10,
CEU SNPs with a MAF≥0.03, in addition to a set of projected Native
American-speciﬁc SNPs (see Section 4.3.2.3). Results are shown for
MXL and PUR in Fig. 5 and Fig. 6, respectively. Coverage is excellent
for both populations for a MAF greater than 0.01. The LAT array
was designed for Latino populations with higher amounts of African
ancestry, such as the PUR individuals; individuals from Mexico have
only a modest degree of African ancestry, on average [20]. Coverage,
however, is excellent for both populations for a MAF greater than
0.01.
Finally, we previously reported the coverage of CEU subjects by
the EUR array [8], using the 1000 Genomes Pilot Phase I data, and
cross validation imputation coverage using 60 individuals. Because
of the small reference sample size, coverage for the array was under-
estimated. Fig. 7 shows the coverage of the EUR array on the CEU pop-
ulation using the much larger reference sample described above. The
coverage is excellent down to a MAF of 0.01. Results were nearly
identical for imputation coverage of FIN, GBR, and TSI (results not
shown).
3. Discussion
While genotyping arrays with millions of SNPs that offer universal
coverage are clearly optimal for GWA studies of multi-racial and
multi-ethnic cohorts, the production time and expense associated
with such arrays was prohibitive for a very large scale project such
as ours. Also, we felt that a single array platform with up to 700,000
SNPs universally applied to individuals of all racial/ethnic back-
grounds was not optimal, because it would provide less coverage
of lower frequency variation overall. Hence, our compromise was to
design race/ethnicity speciﬁc arrays, which could provide coverage0.0 0.2 0.4 0.6 0.8 1.0
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Fig. 7. Chromosome 2 coverage by the AX_KP_UCSF_EUR array of the 1000 Genomes
interim June 2011 release (KG2011) Utah residents with ancestry from Northern and
Western Europe (CEU) genotypes. Coverage was based on imputation of the target
CEU set using all other individuals except CEU. The numbers in parentheses in the leg-
end are the numbers of markers in the target set in each particular minor allele fre-
quency range. Subsets refer to SNPs identiﬁed in the 1000 Genomes High Pass
(KGHP) sequencing (indicated by solid lines with “KGLP ∩ KGHP”) versus all SNPs (in-
dicated by dashed lines with “KGLP, All SNPs”).of both common and rare variation in multiple racial/ethnic groups.
Several advances during the design of the four arrays in this project
led to enhanced coverage. First, the reagent kits developed by Affy-
metrix improved by the time of design of the AFR and LAT arrays,
affording us a wider choice of Axiom validated SNPs to tile onto
those arrays. Second, we developed a novel hybrid SNP selection
scheme which enhanced the ultimate coverage of the AFR and LAT
arrays over what they would have been had SNP selection been
based simply on pairwise tagging. Third, we determined that high
performing SNPs could be tiled with a single representation on the
Axiom arrays without signiﬁcant loss of genotype quality. These latter
three developments were most critical for the AFR and LAT arrays,
where African ancestry required both a larger number of SNPs and
improved SNP selection.
One priority for SNP selection on all three arrays described here
was overlap with the ﬁrst designed array, the EUR array [8]. As a con-
sequence, over 250,000 SNPs are overlapping on all four arrays. These
SNPs represent common variation found in all race/ethnicity groups.
By contrast, across all four arrays, there are over 1.6 million SNPs
represented. This large number reﬂects both common and lower
frequency variation that is race/ethnicity speciﬁc. Many of the SNPs
in this collection of 1.6 million are polymorphic or high frequency in
only one or a few race/ethnicity groups, and monomorphic in others.
One disadvantage of a universal array is that for a given race/ethnicity
group, many of the SNPs on that array will be monomorphic (in
particular if the cost in time or money is a factor). On the other
hand, for SNPs that are polymorphic in two or more race/ethnicity
groups, non-overlap of SNPs on the various arrays means that impu-
tation must be used to create a set of SNPs common to the arrays.
While imputation may be accurate for many of the SNPs, it may not
be accurate for all.
Each array demonstrates good to excellent genome-wide coverage
for the datasets that they were designed to cover. As expected, cover-
age of the EAS, LAT, and CEU arrays are very high, with the AFR array
modestly less. While coverage is substantially greater for SNPs that
appeared in the KG high pass as well as low pass data in general,
the difference is more dramatic for comparisons based on the EAS
array and East Asian populations. The reason for this is likely due to
the number of minor alleles observed in the reference sample,
which can have a strong inﬂuence on imputation coverage for that
SNP. The high pass data were derived from one trio of European an-
cestry and one trio of African ancestry. Hence, SNPs found in the
high pass data are likely to occur in the imputation reference sample
at higher frequency than SNPs found in the low pass data that were
not found in the high pass data (e.g., SNPs that are speciﬁc to East
Asians). This bias has less impact on other arrays and populations. Al-
though our present coverage only uses chromosome 2, we expect the
coverage to be similar to the genome-wide coverage, as we have seen
in other datasets.
We believe that the cost and throughput of next-generation geno-
typing arrays in conjunction with imputation from dense next gener-
ation sequencing data, will aid in the discovery of novel common and
low frequency disease-associated variants, especially when used in
large scale, well phenotyped populations. It is likely that genome-
wide genotyping arrays will continue to be higher throughput and
less expensive than whole genome sequencing. In particular, we
look forward to the identiﬁcation of novel variants associated with a
variety of diseases and traits using the data from these arrays in the
Kaiser Permanente RPGEH.
4. Materials and methods
4.1. The hybrid SNP selection algorithm
A novel hybrid SNP selection algorithm was based on cycles alter-
nating greedy SNP selection based on pairwise tagging with
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sponds to SNPs validated by Affymetrix for use with the Axiom Gen-
otyping Solution that are available for tiling on the array. The target
set of SNPs refers to the set of SNPs for which coverage is attempted
(typically larger than the candidate set and limited to SNPs passing
a MAF cutoff). The selected set of SNPs is the collection of SNPs cho-
sen for tiling on the array after each cycle of SNP selection. The select-
ed set of SNPs increases with each cycle, and the target set of SNPs is
reduced after each cycle.
At each cycle of the hybrid SNP selection, a certain number of
SNPs are selected from the candidate set based on greedy pairwise
coverage and added to the selected set. The selection step is then
followed by a coverage step, wherein the selected set of SNPs is
used to calculate imputation-based coverage for each SNP remain-
ing in the target set. SNPs in the target set with an imputation r2
greater than a given threshold are removed from the target set.
The two steps constitute a single cycle. For computational reasons,
imputation was done without cross validation. Imputation coverage
was calculated as the correlation between dosages of true geno-
types and expected dosages from imputed genotype probabilities
[8,15].
The number of SNPs selected was determined based on the total
number of SNPs that could be covered and the total number of rounds
of SNP selection. In general, more iterations resulted in more efﬁcient
SNP selection (smaller number of selected SNPs to reach the same
coverage), but with greatly increased computational time (primarily
due to the imputation coverage step).
4.1.1. Comparison of hybrid SNP selection to pairwise tagging
We compared the novel hybrid SNP selection strategy to the stan-
dard greedy SNP selection algorithm [8] which is based on pairwise
linkage disequilibrium in terms of expected genome-wide coverage
for the design of the AFR array. We created a hypothetical array
under both strategies to tag 31,119 SNPs from HapMap 3 and some
Affymetrix internal screens with MAF≥0.02 in YRI on chromosome
21, using an imputation r2 cutoff of 0.9 and pairwise r2 cutoff of 0.8.
For the hybrid array, we allowed the hybrid SNP selection algorithm
to run until all markers were covered that could be, which resulted
in selecting 7544 markers. To compare imputation with greedy SNP
selection, we used the ﬁrst 7544 markers chosen by the algorithm
for the second hypothetical array.
We then compared genome-wide coverage of the two hypotheti-
cal arrays by imputing all genotypes for two HapMap samples: the
ASW and the LWK. For each hypothetical array, imputation was
based on the SNPs present on that array. The reference genotype sam-
ple for imputation was the HapMap YRI. Imputation coverage for a
SNP was calculated as the square of the correlation (r2) of the
expected dosages derived from imputation to the dosages derived
from the true genotypes using Beagle version 3.3.0 [21]. Only SNPs
with at least 50 genotypes available in both the reference and target
sample were included in these analyses. Genome-wide coverage
was calculated as the proportion of SNPs in the target sample with a
given imputation r2 value or greater.
4.2. Cluster separation
Cluster separation for a SNP with alleles A and B was assessed
by a Fisher's Linear Discriminant-related Score (FLD Score) [8,22]
which is deﬁned as the minimum of two linear discriminants as
follows:
FLD Score ¼ mini¼AA;BB MAB−Mið Þ=SAA;AB;BB
h i
whereMAB is the center of the heterozygous cluster in the log ratio di-
mension, MAA and MBB are the centers of the two respectivehomozygous clusters in the log ratio dimension, and SAA,AB,BB is the
standard deviation of the clusters pooled across all three distribu-
tions. SNPs with higher FLD Score values are very highly correlated
with tighter clusters and higher call rates.
4.3. SNP selection for inclusion on the arrays
Many of the initial strategies for designing the EAS, AFR, and LAT
arrays were the same as those used for the EUR array, explained in
detail elsewhere [8]. We describe these again brieﬂy here, with an
extended discussion of the modiﬁcations to them.
SNPs that were considered for tiling on the array (candidate set)
were selected based on having good cluster separation (high FLD
Score), a minimum of 3 observed examples of the minor allele (unless
in the primary set as described below), and good accuracy (concor-
dance with HapMap when possible, reproducibility, and consistency
with Mendelian inheritance). SNP selection proceeded progressively
through tiers of importance; SNPs comprising the tiers were updated
during each successive array design. All SNPs, aside from those in the
primary set, were ﬁltered to have allele frequencies above a
certain threshold (discussed below on an array-wise basis).
4.3.1. The preselect set
Primary SNPs were based on strongly conﬁrmed disease associa-
tions from literature and online databases [23,24]. Most were direct-
ly tiled on the array with redundant coverage based on SNPs chosen
for imputation coverage. When adding coverage/redundant cover-
age to the primary SNPs, we ﬁrst selected tag SNPs based on the pop-
ulation of greatest relevance. If a single tag SNP with an r2 greater
than 0.8 with the target SNP was not available, we selected coverage
SNPs by imputation. This entailed greedily adding SNPs so long as it
improved the imputation r2 by more than 0.03. Then, additional
SNPs were selected, if necessary, for tagging the same target SNP
in other relevant populations. Redundant coverage of the same target
SNP was obtained by repeating the imputation tagging process with a
new set of candidate SNPs.
The secondary set consisted of SNPs that were suggestive of asso-
ciation with disease or traits of interest but were not as strongly
replicated as the primary SNPs. This group derived from a variety of
sources [23-26]. When these SNPs could not be directly tiled, cover-
age was obtained by selection of tagging SNPs based on imputation.
This group was not provided with redundant coverage.
The tertiary set consisted of SNPs that were mined from various
database sources for potential functional signiﬁcance (e.g., miRNA,
splice site, MHC, coding, etc., SNPs). When possible (i.e. an Affymetrix
Axiom validated probeset was available), these SNPs were directly
tiled on the array, and they were also included in the ﬁrst target set
for greedy pairwise SNP selection. This ﬁrst target set also included
“gene-enrichment” SNPs in coding regions, adjacent introns and up-
stream and downstream UTR regions of approximately 5000 genes of
interest [8].
4.3.2. Genome-wide coverage
The genome-wide coverage algorithm differed amongst the four
arrays. The EAS array followed a simple greedy SNP selection para-
digm similar to that used for the EUR array, whereas the AFR and
LAT arrays utilized hybrid SNP selection. All 3 of the new arrays de-
scribed here tiled some SNPs with a single representation to increase
the total number of SNPs on the array, although their numbers varied
among arrays. Only the highest resolution SNPs not in the preselect
set were tiled with a single representation.
4.3.2.1. Design of the EAS array. The EAS array was designed primarily
to cover common and rare polymorphisms in East Asians. However,
because some individuals in the RPGEH have mixed East Asian and
European ancestry, we also wanted to optimize this array for such
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polymorphic in East Asians but polymorphic in Europeans down to
a frequency of 0.10. There were 3 rounds of coverage, as follows:
Round 1: To cover tertiary and gene enrichment SNPs in addition to
coverage achieved with the preselect set
• Target sets
• For ASI: Tertiary and gene enrichment SNPs with MAF≥0.01
• For CEU: Tertiary and gene enrichment SNPs with MAF≥0.10
in CEU and absent in the ASI target set
• Candidate set: Axiom validated SNPswith nomore than 2 features
• SNP selection algorithm: Greedy pairwise. The coverage contribu-
tion of a candidate SNP in ASI was the primary factor of consider-
ation. However, other factors, including coverage contribution in
CEU, overlapwith the EUR array, and expected genotyping perfor-
mance were also considered.
• r2 cutoff for pairwise coverage: 0.8
• Termination criterion: Maximal pairwise coverage in both ASI
and CEU is reached
• # SNPs selected: 34,742
Round 2: Additional coverage for tertiary and gene enrichment SNPs
• Target sets: Same as Round 1
• Candidate set: Same as Round 1, except only SNPs in the top tier
of performance
• SNP selection algorithm: Same as Round 1
• r2 cutoff for pairwise coverage: 0.6
• Termination criterion: Same as Round 1
• # SNPs selected: 1,825
Round 3: Genome-wide coverage in addition to coverage achieved
with selected SNPs
• Target sets
• For ASI: genome-wide SNPs with MAF≥0.02
• For CEU: genome-wide SNPswithMAF≥0.10 in CEU and absent
in the ASI target set
• Candidate set: Same as Round 1
• SNP selection algorithm: Same as Round 1
• r2 cutoff for pairwise coverage: 0.8
• Termination criterion: Same as Round 1
• # SNPs selected: 617,168
In round 3, the total number of selected SNPs and featureswas great-
er than could ﬁt on a single array. Therefore, in order to ﬁt all selected
SNPs into a single array, 10% of the SNPs were included using 1 feature
instead of 2 features. These SNPs all have a FLD Score≥8.5 and were
chosen from the end of the ranked selected SNP list.
4.3.2.2. Design of the AFR array. Design of the AFR array took into
account the mixed continental ancestry of African Americans, so
that both African and European SNPs were considered. However, the
lower MAF threshold for the two ancestries was different. We assumed
that for an African American population with approximately 20%
European ancestry [27], it was sufﬁcient to include European-speciﬁc
SNPs with a MAF of 0.10 or greater, as this would translate into a MAF
of 0.02 or greater in an African American sample. There were two
rounds of coverage, as follows:
Round 1: To cover gene enrichment SNPs in addition to coverage
achieved with the preselect set
• Target sets
• For YRI: Gene enrichment SNPs with MAF≥0.01
• For CEU: Gene enrichment SNPs with MAF≥0.10 in CEU and
absent in the YRI target set
• Candidate set: Axiom validated SNPswith nomore than 2 features
• SNP selection algorithm: Greedy pairwise. Candidate SNPs with
FLD Score≥7 were selected before SNPs with FLD Scoreb7.Other factors considered during SNP selection include coverage
in YRI, CEU, overlap with the EUR array, and expected genotyp-
ing performance.
• r2 cutoff for pairwise coverage: 0.8
• Termination criterion: Maximal pairwise coverage in both YRI
and CEU is reached
• # SNPs selected: 136,615
Round 2: Genome-wide coverage in addition to coverage achieved
with selected SNPs
• Target sets
• For YRI: Genome-wide SNPs with MAF≥0.02
• For CEU: Genome-wide SNPswithMAF≥0.10 in CEU and absent
in the YRI target set
• Candidate set: Same as Round 1
• SNP selection algorithm: Hybrid, 9–11 cycles (done on a per
chromosome basis, the number of cycles depended on the chro-
mosome). A quota for SNPs with FLD Scoreb7 was enforced so
that the total number of SNPswith FLD Scoreb7would not exceed
321 k. Once the allowed quota was reached, only SNPs with FLD
Score≥7 were selected. Factors considered during greedy SNP
selection are the same as Round 1.
• r2 cutoff for pairwise coverage: 0.8
• r2 cutoff for imputation coverage: 0.8
• Termination criterion: Maximum space on the array with tiling
SNPs with FLD Score≥7.5 with 1 feature and FLD Scoreb7.5
with 2 features (~170 K SNPs that were covering only singleton
YRI SNPs were removed from the maximum pairwise coverage
of YRI and CEU list)
• # SNPs selected: 695,048
4.3.2.3. Design of the LAT array. Design of the LAT array was the most
complex, because it needed to take into account three different conti-
nental ancestries—African, European and Native American. Adding to
the complexity, Latino populations differ considerably in their relative
proportions of these 3 ancestries [20]. Therefore, we started with cov-
erage in the YRI population, assuming the target Latino population
had up to about 40% African ancestry, on average, for example as has
been observed in Dominicans [28]. We started with SNPs that had
been selected for the AFR array, and then removed and added addition-
al SNPs according to coverage characteristics for the other two ances-
tries. Coverage of European SNPs was based on recent sequence data.
Coverage of Native American SNPs, i.e., those polymorphic in Native
Americans but absent or of low frequency in other race/ethnicity
groups, was complicated by the fact that at the time of design, no
such sequence data for Native Americans or Latinos was available.
Therefore, for coverage of Native American variation, we needed
to rely instead on sources of genotype data for SNPs previously identi-
ﬁed. One of these sources was a sample of 92 Latinos from Kaiser
Permanente Northern California that was genotyped for approximately
5 million SNPs by Affymetrix speciﬁcally to assist SNP selection for the
LAT array. There were 5 rounds of SNP selection, as follows:
Round 1: Choosing SNPs from the AFR array
• SNP selection method: Less important SNPs from the AFR array for
covering SNPs in Latino populations were removed from the AFR
array. These SNPs included those selected during hybrid SNP selec-
tion, with MAFb0.10 in YRI, and that did not cover any CEU target
SNPs at the time of SNP selection; in addition, those selected in
hybrid SNP selection after the end of cycle 5 that did not tag any
CEU target SNPs at the time of SNP selection were removed.
• # SNPs selected: 543,858
Round 2: Genome-wide coverage of CEU in addition to coverage
achieved with selected SNPs
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• For CEU: Genome-wide SNPs with MAF≥0.03
• Candidate set: Axiom validated SNPswith nomore than 2 features
• SNP selection algorithm: Hybrid, consider factors including cov-
erage in CEU, overlap with the EUR array, and expected genotyp-
ing performance
• r2 cutoff for pairwise coverage: 0.8
• r2 cutoff for imputation coverage: 0.8
• Termination criterion:When 244,548 SNPs are selected in 6 cycles
• # SNPs selected: 244,548.
Round 3: Coverage of “Native American” SNPs via HapMap MXL
• Target set
• ForMXL: 19,368 SNPs with MAF≥0.05 in MXL andMAFb0.02 in
both CEU and YRI (to ascertain SNPswith an increased likelihood
of being speciﬁcally increased in frequency in Native Americans)
• Candidate set: All Axiom validated SNPs
• SNP selection algorithm: Greedy pairwise, consider factors includ-
ing pairwise coverage in MXL, number of features a SNP requires,
and expected genotyping performance
• r2 cutoff for pairwise coverage: 0.8
• Termination criterion: Maximal pairwise coverage in MXL is
reached
• # SNPs selected: 9,643
Round 4: Coverage of “Native American” SNPs via KPNC Latino
• Target set
• For the KPNC Latino (described above): 34,953 SNPs with
MAF≥0.05 in Latino and MAFb0.02 in both CEU and YRI
• Candidate set: All Axiom validated SNPs
• SNP selection algorithm: Greedy pairwise, consider factors includ-
ing pairwise coverage in KPNC Latino, number of features a SNP
requires, and expected genotyping performance
• r2 cutoff for pairwise coverage: 0.8
• Termination criterion: Maximal pairwise coverage in KPNC Latino
is reached
• # SNPs selected: 20,365
Round 5: Native American Ancestry Informative Markers
• SNP selection method: Choose Axiom-validated SNPs from 2120
Native American ancestry informative markers (AIMs) from [29]
• # SNPs selected: 1840
Rounds 3–5 produced some overlapping SNPs. Removing the
overlap, the 3 rounds resulted in a total of 28,047 unique “Native
American” SNPs added to the LAT array. All SNPs carried over from
the AFR array for the LAT array were tiled with the same number of
features as in the AFR array. Native American SNPs (described
above) were tiled at half the original number of features when their
FLD Score was at least 7.5. SNPs selected during hybrid SNP selection
were also tiled with a single feature instead of 2 features when their
FLD Score was at least 7.5.
4.4. Estimating genome-wide coverage of the ﬁnal arrays
Genome-wide coverage of the EAS, AFR and LAT arrays was evaluat-
ed by calculating imputation r2 values for all SNPs in the appropriate
target set, as described previously [15] and above. For each array, the
target set included SNPs obtained in the KGHP sequencing effort, but
using the KG2011 genotype data derived for those SNPs from sequenc-
ing the samples. When computing the coverage of speciﬁc racial/ethnic
groups for a given array, we used one population from that racial/ethnic
group in the target, and all other individuals frompopulations of that ra-
cial/ethnic group plus other racial/ethnic groups in the reference. As de-
scribed above, we used the program Beagle version 3.3.0 [21] when
designing the array, but ﬁnal coverage estimates for the array werecalculated using the program Impute2 version 2.1.2 [30] which we
found had slightly higher accuracy, as has been shown before [11].
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